Charles River Laboratories CRL Finance Lease Liabilities (Total)
Finance Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's finance lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's finance lease liabilities (total)?
- Charles River Laboratories (CRL) reported finance lease liabilities (total) of $10.63M in Q1 2026.
- How has Charles River Laboratories's finance lease liabilities (total) changed year-over-year?
- Charles River Laboratories's finance lease liabilities (total) decreased by 63.4% year-over-year, from $29.06M to $10.63M.
- What is the long-term trend for Charles River Laboratories's finance lease liabilities (total)?
- Over 5 years (2020 to 2025), Charles River Laboratories's finance lease liabilities (total) has grown at a -0.8% compound annual growth rate (CAGR), from $29.05M to $27.88M.
- What does finance lease liabilities (total) mean?
- Finance lease liabilities (total) represent the aggregate present value of all future lease payments for assets where the company assumes substantially all risks and rewards of ownership. This metric reflects the long-term debt-like burden associated with financing infrastructure or equipment through leases. It is a key component of the company's total leverage profile.